Clinical Trials Browser

Recruiting × Treatment-Refractory Solid Tumors × Hydroxyurea × Clear all

NCT07190833 2026-04-09

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Phase 1 Recruiting

Other solid neoplasm

Treatment-Refractory Solid Tumors